GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Debt-to-Equity

Raia Drogasil (BSP:RADL3) Debt-to-Equity : 1.20 (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Debt-to-Equity?

Raia Drogasil's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was R$1,585 Mil. Raia Drogasil's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was R$6,110 Mil. Raia Drogasil's Total Stockholders Equity for the quarter that ended in Dec. 2024 was R$6,429 Mil. Raia Drogasil's debt to equity for the quarter that ended in Dec. 2024 was 1.20.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Raia Drogasil's Debt-to-Equity or its related term are showing as below:

BSP:RADL3' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.11   Med: 1.09   Max: 1.2
Current: 1.2

During the past 13 years, the highest Debt-to-Equity Ratio of Raia Drogasil was 1.20. The lowest was 0.11. And the median was 1.09.

BSP:RADL3's Debt-to-Equity is ranked worse than
77.76% of 562 companies
in the Healthcare Providers & Services industry
Industry Median: 0.44 vs BSP:RADL3: 1.20

Raia Drogasil Debt-to-Equity Historical Data

The historical data trend for Raia Drogasil's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Debt-to-Equity Chart

Raia Drogasil Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.11 1.13 1.19 1.20

Raia Drogasil Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 1.15 1.23 1.20 1.20

Competitive Comparison of Raia Drogasil's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Debt-to-Equity falls into.


;
;

Raia Drogasil Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Raia Drogasil's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Raia Drogasil's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (BSP:RADL3) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Raia Drogasil Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company is engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines. Its brands include Impulso, Amplimed, HealthBit, Stix, 4Bio, Drogasil, Raia and others.

Raia Drogasil Headlines

No Headlines